ARTICLE | Clinical News
Exforge cardiovascular data
May 22, 2006 7:00 AM UTC
Data from a double-blind, active-controlled study in 130 patients with stage 2 uncomplicated hypertension showed that those treated with Exforge had an average systolic blood pressure (SBP) reduction ...